Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 223-228

  Milewski, S ^a   Mignini, F ^a   Prasad, R ^a   Borowski, E ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

[N3 (4 METHOXYFUMAROYL) 2,3 DIAMINOPROPANOIC ACID]PEPTIDE DERIVATIVE; ANTIFUNGAL AGENT; CYCLOHEXIMIDE; PEPTIDE DERIVATIVE; PYRROLE DERIVATIVE; TERBINAFINE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DRUG TRANSPORT; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTIFUNGAL; BETA-ALANINE; CYCLOHEXIMIDE; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; FUMARATES; GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE (ISOMERIZING); HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PROTEIN SYNTHESIS INHIBITORS; PROTONS; SACCHAROMYCES CEREVISIAE;

EID: 0035165769     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.223-228.2001     Document Type: Article

References (37)

1. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
2. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1
3. Cloning of a Candida albicans peptide transport gene
4. Peptide transport in yeast: Uptake of radioactive trimethionine in Saccharomyces cerevisiae
5. Fungal peptide transport as a drug delivery system
6. The Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene
7. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding
8. Mode of action of 5-fluorocytosine
9. Modified colorimetric ninhydrin method for peptidase assay
10. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR 1 protein
11. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance
12. Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation
13. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides
14. Evidence for a proton/sugar symport in the yeast Rhodotorula gracilis (glutinis)
15. i and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
16. Yeast nutrient transporters
17. Regulation of dipeptide transport in Saccharomyces cerevisiae by micromolar amino acid concentration
18. The mode of action of bacilysin and anticapsin and biochemical properties of bacilysin-resistant mutants
19. Anticancer drugs, ionophoric peptides and steroids as substrates of the yeast multidrug transporter Pdr5
20. Cloning by gene amplification of two loci conferring multiple drug resistance
21. An oligopeptide transport gene from Candida albicans
22. Relative rates of transport of peptidyl drugs by Candida albicans
23. Substrate specificity of peptide permeases in Candida albicans
24. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase
25. Transport and hydrolysis of peptides in Saccharomyces cerevisiae
26. Proton-dependent multidrug efflux systems
27. Limitations to the use of radioactively labelled substrates for studying peptide transport in microorganisms
28. Isolation and characterization of a Saccharomyces cerevisiae peptide transport gene
29. Molecular cloning and characterisation of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
30. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
31. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterisation of CDR2, a new multidrug ABC transport gene
32. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores
33. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: Peptide binding and erects on drug transport and accumulation
34. The PTR family: A new group of peptide transporters
35. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
36. Reversal mechanism of multidrug resistance by verapamil. Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells